Terry Booth
TORONTO, NEW YORK—Eyecarrot Innovations Corp. (TSX-V:EYC) has named Aurora Cannabis (TSX-ACB) founder and former CEO, Terry Booth, as executive chairman. Booth was one of the two original founders of Aurora Cannabis Inc. Booth has a deep knowledge of highly regulated environments, according to a statement from Eyecarrot. He was instrumental in Aurora receiving its initial licensing and approval from Health Canada to produce medical cannabis, as well as building the company’s state of the art cultivation facility Aurora Sky.

With this strong entrepreneurial vision running through the entire company, Terry has overseen the company’s organic growth as well as its expansion through acquisitions of companies, all of which were successfully integrated into the parent company.

Booth has been involved in over 30 M&A transactions and acquisitions in the last five years, and has more than 25 years of experience in creating, growing and leading companies in highly regulated industries. He sits on the board of Aurora Cannabis, Quinsam Capital, and Psyched Wellness and has sat on the board of other organizations, including Radient Technologies and Alcanna (formerly Liquor Stores N.A.). Booth has also served as president/CEO of Superior Safety Codes, which was recognized as one of Canada’s top 50 fastest-growing companies.


Eyecarrot also announced that is as arranged a non-brokered private placement to raise up to $1 million through the issuance of up to 7,843,137 units at a price of $0.1275 per unit, subject to the approval of the TSX Venture Exchange. The proceeds of the placement will be utilized for the further development of the company’s products and for general working capital purposes. Booth is expected to subscribe for up to 1,960,785 units of the financing.

The company also announced the grant of an aggregate of 2,500,000 stock options at an exercise price of $0.17 per share for a period of five years to directors, officers, employees and consultants, of which 500,000 stock options will be granted to Booth.

Dr. John Flanagan has resigned from Eyecarrot’s board of directors of the company to make room for Booth, and will now be the first member of the company’s scientific advisory board.